Breaking News

You are here » Indian-Commodity  :  Commodities  :  Cashew  :  Cashew kernel exports fell by 25% in April-September period

21-Oct2016

Cashew kernel exports fell by 25% in April-September period

The exports of cashew kernel right from the beginning of the current fiscal has been showing a declining trend on account of high price of raw nuts. Cashew exports fell by 25% to 36,895 tonnes valued at Rs 2,138 crore for six months to September 30, 2016, from a year ago. The drop in value was 13%, as per the data compiled by the Cashew Export Promotion Council of India.

The raw nut imports by India slumped by as much as 31% to 5,00,329 tonnes for six months. At present Tanzania is the chief supplier of raw cashew nuts as the season is over in West African countries like Ghana and Ivory Coast.

In 2015-16, India exported 94,150 tonnes valued at Rs 4,850 crore. This was 21% lower in quantity and 11% in value over the previous year.




Related News

View all news

Cashew kernel exports fell by 25% in April-September period

The exports of cashew kernel right from the beginning of the current fiscal has been showing a declining trend on account of high price of raw nuts. Cashew exports fell by 25% to 36,895 tonnes valued at......

India's Cashew export falls during April -July 2016

India's Cashew export falls sharply in April -July 2016 by 24% in volume and 14% in value from that of the corresponding period last fiscal.During the period, total shipments fell to 24,833 tons valued......

Cashew Nut Rates Up 20%

Cashew nut rates in the Palasa Kasibugga current market have raised by over 20 % for the duration of......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......